CIAS
COGT icon

CBIZ Investment Advisory Services’s Cogent Biosciences COGT Stock Holding History

CBIZ Investment Advisory Services’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3
Closed -$22 – 697
2025
Q2 		$22 Hold
3
– – ﹤0.01% 731
2025
Q1 		$18 Hold
3
– – ﹤0.01% 610
2024
Q4 		$23 Buy
+3
New +$30 ﹤0.01% 469

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

CBIZ Investment Advisory Services's COGT Position: Q3 2025 in Review

CBIZ Investment Advisory Services sold out of Cogent Biosciences (COGT) in Q3 2025, closing a stake of 3 shares — an estimated $22 sold.

CBIZ Investment Advisory Services first reported a position in COGT in Q4 2024 and held it in 3 quarters. The position peaked at $23 in Q4 2024. 195 funds tracked by Wall St. Rank hold COGT as of Q3 2025.

  • CBIZ Investment Advisory Services reported no remaining Cogent Biosciences position as of Q3 2025 after selling out during the quarter.
  • CBIZ Investment Advisory Services sold 3 Cogent Biosciences shares in Q3 2025, an estimated $22.
  • CBIZ Investment Advisory Services first reported a position in Cogent Biosciences in Q4 2024 and held it in 3 quarters.
  • CBIZ Investment Advisory Services's Cogent Biosciences position peaked at $23 in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2025.

Based on CBIZ Investment Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.